Lung Cancer & Genomics: What do we Know?

Genomics|Update|Current

Lung Cancer & Genomics: What do we Know?

The Lancet features a series of papers on lung cancer. Topics include immunotherapy, screening for earlier diagnosis, patient management, and tumour biomarkers and genetics, August 2013
Genetics and biomarkers in personalisation of lung cancer treatment.
Rosell R, et al. Lancet, 2013 Aug 24
EGFR mutation tumor analysis has been recommended in personalization of treatment of non-small cell lung cancer by several evidence-based groups. Check out CDC tier 1 genomic applications table for more details
CDC paper: Utilization of epidermal growth factor receptor (EGFR) testing in the United States: Still far from optimal
Genetics in Medicine (2013)
CDC Lung cancer information
National Cancer Institute: Lung Cancer: Prevention, Genetics, Causes
Did you know? More than 1000 genes have been reported in relation to lung cancer risk and outcomes, including 53 genomewide association studies. To find out more, visit the HuGE Navigator